Agilent Technologies Inc
NYSE:A
Agilent Technologies Inc
Cash Equivalents
Agilent Technologies Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Agilent Technologies Inc
NYSE:A
|
Cash Equivalents
$1.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash Equivalents
$8.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
31%
|
CAGR 10-Years
3%
|
|
Danaher Corp
NYSE:DHR
|
Cash Equivalents
$5.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
49%
|
CAGR 10-Years
7%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash Equivalents
$853.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash Equivalents
$69.8m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-5%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash Equivalents
$1.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
See Also
What is Agilent Technologies Inc's Cash Equivalents?
Cash Equivalents
1.7B
USD
Based on the financial report for Jan 31, 2024, Agilent Technologies Inc's Cash Equivalents amounts to 1.7B USD.
What is Agilent Technologies Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
-4%
Over the last year, the Cash Equivalents growth was 40%. The average annual Cash Equivalents growth rates for Agilent Technologies Inc have been 10% over the past three years , -3% over the past five years , and -4% over the past ten years .